A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Institut Curie
Medical College of Wisconsin
Targeted Therapy Technologies, LLC
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Chengdu Kanghong Biotech Co., Ltd.
Ann & Robert H Lurie Children's Hospital of Chicago
Stanford University
Hospital Sant Joan de Deu
NYU Langone Health
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Sun Yat-sen University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Stanford University
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital